Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Remission of metastatic cervical adenocarcinoma with weekly paclitaxel
Autore:
Ota, S; Sugiyama, T; Ushijima, K; Fujiyoshi, K; Komai, K; Hirai, N; Nishida, T; Kamura, T;
Indirizzi:
Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan Kurume Univ Kurume Fukuoka Japan 8300011 , Kurume, Fukuoka 8300011, Japan
Titolo Testata:
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
fascicolo: 2, volume: 11, anno: 2001,
pagine: 167 - 168
SICI:
1048-891X(200103/04)11:2<167:ROMCAW>2.0.ZU;2-0
Fonte:
ISI
Lingua:
ENG
Soggetto:
TAXOL;
Keywords:
adenocarcinoma; cervical cancer; paclitaxel;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
7
Recensione:
Indirizzi per estratti:
Indirizzo: Sugiyama, T Kurume Univ, Sch Med, Dept Obstet & Gynecol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan Kurume Univ 67 Asahi Machi Kurume Fukuoka Japan 8300011 Japan
Citazione:
S. Ota et al., "Remission of metastatic cervical adenocarcinoma with weekly paclitaxel", INT J GYN C, 11(2), 2001, pp. 167-168

Abstract

We report the use of paclitaxel in the successful treatment of a patient with recurrent adenocarcinoma of the cervix. Paclitaxel, 70 mg/m(2) by 1-h infusion weekly, was administered to a 59-year-old patient with cervical adenocarcinoma showing lung metastasis. She showed partial clinical response after seven cycles, and at the completion of 20 cycles she showed complete response, which was confirmed by chest X-ray and computed tomography scan. Toxicities including neurotoxicity were mild. She showed an objective response to treatment for over 8 months, and she enjoyed a favorable quality of life during and after treatment. Weekly paclitaxel was very well tolerated, yet was effective for recurrent cervical adenocarcinoma.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/09/20 alle ore 07:31:04